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SUMMARY Metatypical carcinoma (MTC) or basosquamous 
carcinoma is a remarkable malignancy with features of both 
basal and squamous cell carcinoma. It is typically located on the 
back and face, often with clinical features of basal cell carcinoma 
but tending to be more aggressive with enhanced prospects of 
lymph node or distant metastases. Our report describes a huge 
neglected MTC of the back of ten-year duration, a giant ulcero-
vegetative tumor measuring 20x25 cm. Histologic examination 
of specimens from the margins and periphery revealed aspects 
of both basal and squamous cell carcinoma, while the ulcerated 
center showed sclerotic tissue without tumor. Radical excision 
and reconstruction by grafts were performed. No metastases 
were observed after two years. There are many controversies 
surrounding the histologic definition and biologic behavior 
of MTC, including its metastasizing potential. The MTC we 
describe exhibited benign biologic behavior. This may have 
been related to an intense inflammatory host response with 
elimination of neoplastic tissue and consequent local sclerosis 
evident in the central tumor-free portion. This central tumor 
regression is to our knowledge a unique finding in MTC.
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INTRODUCTION
 Metatypical carcinoma (MTC), also known as 
basal squamous cell carcinoma and basal squa-
mous cell epithelioma, has been recognized for 
many decades, characterized as an aggressive 
variant of basal cell carcinoma with histologic 
features of squamous cell carcinoma (1-10). The 
World Health Organization histologic classification 
of skin tumors distinguishes it as a nosologic vari-
ety of skin carcinoma (11). This neoplasm is clini-
cally similar or identical to basal cell carcinoma 
(BCC), and is histologically characterized by the 
lack of peripheral nuclear palisading in some cellu-
lar lobules and presence of different types of cells 
either with larger nuclei and abundant eosinophilic 
cytoplasm, or occasionally with a spindle cell ap-
pearance and prominent intercellular bridges.
 Separating MTC from a typical BCC is impor-
tant from the a prognostic standpoint because this 
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tumor is more likely to be aggressive locally and to 
metastasize (4,8,9,12-16). The patient we describe 
had a giant form of MTC that did not metastasize 
even after 12 years from its appearance, perhaps 
related to an intense tissue reaction and central 
neoplastic regression, the latter to our knowledge 
not noted previously with MTC. 
CASE REPORT
 A 70-year-old woman of low socioeconomic 
status was first seen with a huge ulcer on the right 
upper buttock. It had slowly grown for 10 years, 
painlessly but with occasional pruritus, and began 
to ulcerate three years before. She had neglected 
the tumor, not seeking medical assistance.
 On physical examination the ulcer measured 
20x25 cm in diameter and involved the whole low-
er part of the right back with extension to the right 
buttock (Fig. 1). It did not appear homogeneous, 
with undermined rolled margins and an exophytic 
lateral portion (Fig. 2). Clinically, it resembled a gi-
ant ulcerated BCC. There was no hepatospleno-
megaly or lymphadenopathy. Altered laboratory 
test values showed moderate microcytic anemia 
with hemoglobin of 7.70 g/dL (12-16 g/dL) and 
hematocrit 24.60% (42%-52%); platelets 488,000 
(nl, 130,000-400,000); serum creatinine 2.28 
mg/dL (0.70-1.50); urea nitrogen 25.6, calcium 
8.23 mg/dL (8.50-10.20), and sodium 130 mmol 
(135-145 mmol). Serum electrophoresis revealed 
hypoproteinemia of 5.60 g/dL (6.0-8.5 g/dL) and 
hypoalbuminemia of 2.89 g/dL (3-5 g/dL). Microbi-
ologic culture from the ulcer showed the presence 
of both beta-hemolytic Streptococcus and Pseu-
domonas aeruginosa. Radiologic examinations 
including magnetic resonance imaging (MRI) did 
not reveal any metastastic disease. The patient 
was initially treated with liquids, blood and plasma 
transfusions, diuretics and antibiotics.
 Surgical treatment consisted of radical excision 
with 2-cm margins. The deep muscular layer was 
apparently healthy, so the whole area was cov-
ered by split thickness skin grafts. The neoplasm 
was divided into four quadrants. Nine full thick-
ness biopsies were taken: two from each quadrant 
and one from the center. Histologic examination 
revealed a metatypical carcinoma. The patient 
was monitored every two months for a period of 
two years with no evidence of local recurrence or 
distant metastasis.
HISTOLOGY
 Microscopic evaluations revealed different find-
ings in the nine histologic blocks obtained from 
multiple areas of the lesion. The histologic fea-
tures diagnostic of MTC were characterized by 
three main aspects: basal, squamous and inter-
mediate. The basal aspect showed large islands 
of epithelial cells with the characteristic palisading 
at the periphery, without evidence of cell matura-
tion or differentiation (Fig. 3). The evidence of epi-
thelial cells arranged in a whirly appearance with 
numerous apoptotic cells and a high mitotic index 
was observed (Fig. 4). 
 Histologic findings in other areas showed as-
pects of squamous cell carcinoma with islands 
of epithelial cells, differing in size and shape, 
Figure 1. A huge neglected ulcer on the right up-
per buttock. 
Figure 2. Focal exophytic aspect of the neo-
plasm.
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infiltrating the underlying dermis, and foci of kera-
tinization with horny pearls (Fig. 5). The intermedi-
ate aspect had areas of epithelial undifferentiated 
spindle cells where characteristics of both basal 
and squamous cell carcinoma were unrecogniz-
able (Fig. 6). Moreover, there were areas where 
the two basal and squamous features coexisted 
within the same islands of neoplastic cells. A pe-
ripheral basaloid area with palisading and foci of 
squamous differentiation in the central zone were 
evident in these fields. In the central portion of 
this neoplasm the skin appeared ulcerated, with 
granulation and inflammatory tissue, and the lack 
of tumor (Fig. 7).
DISCUSSION
 Metatypical carcinoma was first described in 
1910 (1). In 1937, MacKee and Cipollaro (4) ob-
served that basal squamous cell carcinoma was 
known by the French as épithéliome metatypique, 
épithéliome mixte, or épithéliome pavimenteux et 
intermédaire, and had been described previously 
by a number of authors (2,3). MacKee and Cipol-
laro (4) commented: “It has been known for many 
years that about 10 or 15 per cent of clinical basal-
cell epitheliomas contain prickle or squamous epi-
thelial cells”.  Montgomery (2) found characteristics 
of MTC in 12.6% of a series of 119 cases of clinical 
basal cell epithelioma. This type of neoplasm had 
been noted then and has been observed since to 
be clinically indistinguishable from the BCC, but 
with a course more likely to be rapid with metasta-
ses and death, the findings consistent with recent 
studies (7-13).  MTC has thus been widely recog-
nized for a long time as a specific entity, defined 
as a neoplasm with the features of BCC with foci 
of squamous differentiation and spindle cell ar-
eas. The tumor lobules are more irregular and pe-
ripheral palisading is less pronounced but focally 
present. Stromal proliferation is more prominent. 
Often, areas of typical BCC may be seen to merge 
Figure 3. Basal aspect of the tumor demonstrat-
ing large islands of epithelial cells with character-
istic palisading at the periphery, without evidence 
of cell maturation or differentiation. (hematoxylin-
eosin, magnification x25).
Figure 4. Epithelial cells arranged in a whirly ap-
pearance with numerous apoptotic cells and a 
high mitotic index (hematoxylin-eosin, magnifica-
tion x25).
Figure 5. Histologic aspects of the squamous cell 
carcinoma with islands of epithelial cells differing 
in size and shape, infiltrating the underlying der-
mis. Note foci of keratinization with horny pearls. 
(hematoxylin-eosin, magnification x10)
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into a metatypical region. The most important his-
tologic finding that confirms the MTC diagnosis 
is the absence of a transition zone between the 
basal cell and squamous cell types. Thus, MTC 
is not a collision between BCC and SCC. MTC is 
generally considered more aggressive than the 
common BCC or the sun-induced cutaneous SCC 
(4,7,12-16). Metastases occur mainly to the lung, 
bone, lymph node, liver, spleen and adrenal gland 
(9). In our case, despite a relatively long history 
(12 years) and protracted clinical course produc-
ing a giant-sized tumor, its biologic behavior was 
relatively benign since there was no evidence of 
local recurrence and no distant metastases. To 
our knowledge, this is one of the largest if not the 
biggest metatypical carcinoma described. Another 
was noted to involve the anterior scalp, left orbit 
and left side of the face (12). 
 Metatypical carcinoma is a well-recognized 
entity within the group of skin epitheliomas. In 
a retrospective study of 2075 skin cancers from 
pathology records, 31 MTCs were identified in 28 
patients, with a median age at diagnosis being 68 
(range, 10-94) years (16). Thus, MTCs constituted 
1.5% of the total number of skin cancers. Most 
were located on the head and neck. It may be seen 
in many settings, including in association with ne-
vus sebaceous and with xeroderma pigmentosum 
(17,18). The clinical diagnosis is difficult and must 
be confirmed by histologic findings. The course of 
the tumor may be aggressive with the potential of 
recurrence and distant metastases. The aggres-
sive course may be attributed to the immune re-
sponse of the patient, size of the lesion, and de-
gree of anaplasia of the squamous cell carcinoma 
component which is responsible for the potential 
of metastasis, since the basal cell carcinoma rare-
ly metastasizes (13-16). Therefore, although the 
tumor dimension can play an important role in the 
prognosis, the emphasis should be on histologic 
findings, especially the squamous cell carcinoma 
component. We wonder if the benign biologic be-
havior in our patient may have been related to her 
strong inflammatory host response with the elimi-
nation of neoplastic tissue and the consequent 
local sclerotic tissue reaction that was evident in 
the central tumor-free portion. This is to our knowl-
edge a unique finding.
 A number of histologic and immunohistochemi-
cal techniques have been utilized to compare the 
MTC, BCC, and SCC (10,19-21). In a study of 
markers, all stained to varying degrees the ma-
lignant aspects of the specimens, with similar 
patterns between tumors, the MTC showing a 
transition zone between typical BCC and SCC. 
This was most striking for Ber-EP4, where over 
two-thirds of the BCCs stained, none of the SCCs, 
and half of the MTCs demonstrated reactivity (10). 
Another study found the values of the mitotic regi-
men in MTC to differ from similar values in BCC: 
the mitotic activity, the specific content of dividing 
cells at the stage of metaphase, and the rate of 
pathologic mitoses were considerably increased. 
Multipolar and monocentric mitoses as well as 
Figure 6. Intermediate aspect with areas of epi-
thelial undifferentiated spindle cells where char-
acteristics of both basal and squamous cell car-
cinoma are unrecognizable. (hematoxylin-eosin, 
magnification x25)
Figure 7. Central portion with granulation tissue, 
inflammation and absence of tumor. (hematoxylin-
eosin, magnification x10)
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intercellular bridges were present in MTC (21). 
Some have questioned the existence of MTC, be-
lieving it may represent either a keratotic BCC or 
a BCC with differentiation into two cell types (7, 
22-25). However, since BCC is derived from em-
bryonal pluripotential cells and SCC is a neoplasm 
of anaplastic ones, we favor the postulation that a 
cell population within BCC differentiates towards 
an SCC to produce a MTC (7,26). 
 The best therapeutic approach is complete re-
section with negative surgical margins and long-
term follow-up for early detection of the possible 
local recurrence and distant metastatic spread 
(16,22). In a retrospective study, 745 BCCs, 228 
SCCs, and 27 MTCs (1,000 tumors in total) were 
treated in 580 patients (9). The average number of 
stages required for clear margins in cases of BCC, 
SCC, and MTC was found to be 1.62, 1.51, and 
2.00, respectively. The prevalence of metastasis 
was 0.87% for SCC and 7.4% for MTC, which was 
statistically significant (p<0.001). MTCs displayed 
tissue invasion similar to that of BCC or SCC but 
had a higher frequency of pulmonary metastasis 
than SCC. The prognosis depends on many fac-
tors, including the morphology and histology of 
the tumor as well as the immune status of the pa-
tient. 
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